Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3

NCT07167134 is registered in ClinicalTrials.gov with Centre Paul Strauss as lead sponsor.

NCT NCT07167134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07167134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3
Lead sponsor
Centre Paul Strauss
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
April 30, 2030
Enrollment
264 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases